| P2093 | author name string | Cripe LD | |
| P2860 | cites work | Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B | Q28247684 |
| | Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations | Q28262023 |
| | Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group | Q28296408 |
| | The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia | Q28320997 |
| | Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) | Q33235500 |
| | Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial | Q33490009 |
| | Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group | Q34692984 |
| | Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B. | Q34722375 |
| | Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study | Q34992477 |
| | On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group | Q35155166 |
| | Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia | Q35390119 |
| | High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study | Q35982210 |
| | Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: a study of 343 patients | Q36469510 |
| | Treatment of resistant acute myeloid leukemia | Q36933678 |
| | A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study | Q39233227 |
| | Contribution of immunophenotype in the diagnosis and classification of haemopoietic malignancies | Q39643677 |
| | Failure of remission induction in acute myelocytic leukemia | Q40547433 |
| | Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia | Q40746796 |
| | High-dose cytosine arabinoside and L-asparaginase therapy for poor-risk adult acute nonlymphocytic leukemia. A retrospective study | Q40761253 |
| | Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature | Q40782576 |
| | Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia | Q40805621 |
| | The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer | Q40996275 |
| | Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remission | Q41061537 |
| | Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia. | Q41596669 |
| | High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia | Q42384102 |
| | Marrow transplantation from related donors other than HLA-identical siblings | Q43519981 |
| | Long term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group (ECOG) experience | Q43660590 |
| | Granulocyte-macrophage colony stimulating factor (GM-CSF) priming in the treatment of elderly patients with acute myelogenous leukemia | Q43685559 |
| | Treatment of relapsed or refractory adult acute lymphocytic leukemia | Q44118279 |
| | Intensive treatment of acute leukemia in adults 70 years of age and older | Q44651426 |
| | Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol | Q45112323 |
| | Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission | Q45267630 |
| | Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission | Q46743348 |
| | All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia | Q47228504 |
| | High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study. | Q52608444 |
| | Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. | Q52881409 |
| | Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group. | Q53010515 |
| | Treatment of acute myeloid leukemia in elderly patients. A retrospective study. | Q53795241 |
| | Quantitation of resistance of leukemic cells to cytosine arabinoside from BrdUrd/DNA bivariate histograms | Q53810416 |
| | A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA. | Q54307181 |
| | Response to salvage therapy and survival after relapse in acute myelogenous leukemia. | Q54348128 |
| | Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid. | Q55052259 |
| | Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation | Q67717717 |
| | Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience | Q68012998 |
| | Microgranular variant of acute promyelocytic leukemia in children | Q68034490 |
| | The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B | Q68043727 |
| | Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies | Q68196174 |
| | A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia | Q68232920 |
| | Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia | Q68514600 |
| | Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia | Q68559342 |
| | Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly | Q68700843 |
| | Prognostic factors at relapse for adults with acute myeloid leukemia | Q68704695 |
| | Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia | Q68768842 |
| | Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide | Q68885727 |
| | High-dose Ara-C (HiDAC) plus asparaginase in elderly patients with acute non-lymphocytic leukemia: a pilot multicentric study by the Italian Cooperative Group GIMEMA | Q69484184 |
| | Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission | Q69486033 |
| | Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: a prospective controlled trial | Q69510193 |
| | Attenuated high-dose cytosine arabinoside in the treatment of the elderly patient with acute nonlymphocytic leukemia. An Eastern Cooperative Oncology Group Pilot Study | Q69623718 |
| | The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years | Q69960917 |
| | Remission rate and survival in acute myeloid leukemia: impact of selection and chemotherapy | Q70138881 |
| | Full dose versus attenuated dose daunorubicin, cytosine arabinoside, and 6-thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly | Q70369165 |
| | Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia | Q70505788 |
| | Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia | Q70505791 |
| | Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens | Q70543533 |
| | Autologous bone marrow transplant in acute myeloid leukemia in first remission | Q70543537 |
| | Acute promyelocytic leukemia | Q70772271 |
| | Correlation of morphological FAB classification and immunophenotyping: value in recognition of morphological, cytochemical and immunological characteristics of mixed leukaemias | Q70778418 |
| | Treatment of newly-diagnosed acute myelogenous leukaemia in patients aged 80 years and above | Q71028615 |
| | Serum LDH value as a predictor of clinical outcome in acute myelogenous leukaemia of the elderly | Q71045108 |
| | The GIMEMA ALL 0183 trial: analysis of 10-year follow-up. GIMEMA Cooperative Group, Italy | Q71045128 |
| | Bone marrow transplantation from partially HLA-matched related donors in adults with leukaemia: the experience at the University Hospital of Essen, Germany | Q71045248 |
| | Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologìa ed Ocologia Pediatrica | Q72015394 |
| | The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen‐year period | Q72078948 |
| | Treatment of acute myelogenous leukemia in patients over 50 years of age with V-TAD: a Southwest Oncology Group study | Q72157272 |
| | Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia | Q72229025 |
| | Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia | Q72256230 |
| | Chemotherapy in acute myelogenous leukemia: high dose, higher expectations? | Q72354100 |
| | Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad | Q72377470 |
| | Incorporating patients' preferences into medical decisions | Q72476898 |
| | Improved survival for patients with acute myelogenous leukemia | Q72616310 |
| | Prognostic factors in elderly patients with acute myeloid leukaemia: development of a model to predict survival | Q72705328 |
| | Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission | Q72790360 |
| | The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients | Q72800468 |
| | Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing | Q72850634 |
| | Inv(16) may be one of the only 'favorable' factors in acute myeloid leukemia: a report on 19 cases with prolonged follow-up | Q72898279 |
| P433 | issue | 1 | |
| P921 | main subject | acute leukemia | Q976388 |
| P304 | page(s) | 1-64 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Current Problems in Cancer | Q15756751 |
| P1476 | title | Adult acute leukemia | |
| P478 | volume | 21 | |